Scientific papers can use CAMP, hCAP-18 and LL-37 in closely related discussions. They do not always describe the same measured material. A gene-expression result, a precursor-protein measurement and an experiment with a cleaved peptide should be recorded separately. This distinction matters when a laboratory observation is used to support a product claim.
The original processing experiment
Sørensen and colleagues’ 2001 study investigated how human hCAP-18 is cleaved to release LL-37. In the neutrophil setting examined, the researchers identified extracellular processing by proteinase 3 after exocytosis. They did not detect the same cleavage inside cells after phagocytosis. The result described a specific biological processing step, rather than a clinical trial of an administered preparation.
A precursor can therefore be present without the experiment establishing the same quantity of released peptide at the relevant site. Likewise, an increase in messenger RNA does not, on its own, demonstrate a proportional increase in active extracellular LL-37. Translation, processing and location are additional questions. Keep the measured level of the pathway attached to the finding.
A three-column reading method
| Measured item | What to ask |
|---|---|
| CAMP RNA | Was this a gene-expression experiment? |
| hCAP-18 | Did the assay identify precursor protein? |
| LL-37 | Was the released peptide distinguished from related material? |
This approach is useful when comparing papers that appear to disagree. They may have measured different stages, tissues or time points. Before concluding that one refutes another, inspect the assay and specimen. A similar name in the introduction does not establish that the methods measured the same biological entity.
What this means for treatment claims
A drug made outside the body is another intervention. Its formulation, route, distribution and effects must be studied rather than inferred from the existence of an endogenous processing pathway. “The body makes it” does not demonstrate that an externally supplied preparation reproduces the same local conditions or improves a particular outcome.
When reading an offer, ask whether its supporting citation measured endogenous expression, precursor cleavage or administered peptide. Ask which human outcome connects that observation to the proposed use. The processing paper is valuable because it makes the biology more precise. Its value is lost when all stages are collapsed into a general statement that supplying more LL-37 must be beneficial.
Sources and reading scope
Research draft prepared November 7, 2026. This is educational synthesis, not medical review or an individualized treatment recommendation. Check the linked original records and current labels before making a decision.